Literature DB >> 20151202

Nutritional issues in treating phenylketonuria.

François Feillet1, Carlo Agostoni.   

Abstract

A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients' growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151202     DOI: 10.1007/s10545-010-9043-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  54 in total

Review 1.  The muscle-bone relationship: methods and management - perspectives in glycogen storage disease.

Authors:  Eckhard Schönau; Bernd Schwahn; Frank Rauch
Journal:  Eur J Pediatr       Date:  2002-09-05       Impact factor: 3.183

2.  Fish oil supplementation improves visual evoked potentials in children with phenylketonuria.

Authors:  S Beblo; H Reinhardt; A C Muntau; W Mueller-Felber; A A Roscher; B Koletzko
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

3.  A longitudinal study of antioxidant status in phenylketonuric patients.

Authors:  Rafael Artuch; Catrina Colomé; Cristina Sierra; Nuria Brandi; Nilo Lambruschini; Jaume Campistol; Dolores Ugarte; Maria A Vilaseca
Journal:  Clin Biochem       Date:  2004-03       Impact factor: 3.281

Review 4.  Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition.

Authors:  Carlo Agostoni; Tamas Decsi; Mary Fewtrell; Olivier Goulet; Sanja Kolacek; Berthold Koletzko; Kim Fleischer Michaelsen; Luis Moreno; John Puntis; Jacques Rigo; Raanan Shamir; Hania Szajewska; Dominique Turck; Johannes van Goudoever
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-01       Impact factor: 2.839

5.  Bone mineral status in children with phenylketonuria under treatment.

Authors:  A Al-Qadreh; K H Schulpis; H Athanasopoulou; C Mengreli; A Skarpalezou; I Voskaki
Journal:  Acta Paediatr       Date:  1998-11       Impact factor: 2.299

6.  [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria].

Authors:  Jadwiga Ambroszkiewicz; Joanna Gajewska; Magdalena Chełchowska; Mariusz Ołtarzewski; Teresa Laskowska-Klita; Maria Nowacka; Andrzej Milanowski
Journal:  Pol Merkur Lekarski       Date:  2008-07

7.  Position of the American Dietetic Association and Dietitians of Canada: vegetarian diets.

Authors: 
Journal:  Can J Diet Pract Res       Date:  2003       Impact factor: 0.940

Review 8.  The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.

Authors:  M Wajner; A Latini; A T S Wyse; C S Dutra-Filho
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control.

Authors:  Bernd Schwahn; Frank Rauch; Udo Wendel; Eckhard Schönau
Journal:  J Pediatr       Date:  2002-09       Impact factor: 4.406

10.  Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: a cross-sectional and longitudinal study.

Authors:  J P Rake; G Visser; D Huismans; S Huitema; E van der Veer; D A Piers; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

View more
  20 in total

1.  New insights in growth of phenylketonuric patients.

Authors:  María L Couce; Ipek Guler; Andrés Anca-Couce; Marta Lojo; Alicia Mirás; Rosaura Leis; Alejandro Pérez-Muñuzuri; José M Fraga; Francisco Gude
Journal:  Eur J Pediatr       Date:  2014-11-01       Impact factor: 3.183

Review 2.  Antioxidant treatment strategies for hyperphenylalaninemia.

Authors:  Priscila Nicolao Mazzola; George Albert Karikas; Kleopatra H Schulpis; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-05-09       Impact factor: 3.584

3.  Outcomes of phenylketonuria with relevance to follow-up.

Authors:  F J van Spronsen; A Bélanger-Quintana
Journal:  JIMD Rep       Date:  2011-06-22

Review 4.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

5.  Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats.

Authors:  Simone Luisa Berti; Guilherme Marmontel Nasi; Cristina Garcia; Fernanda Luz de Castro; Michely Lopes Nunes; Denise Bertin Rojas; Tarsila Barros Moraes; Carlos Severo Dutra-Filho; Clóvis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2011-11-19       Impact factor: 3.584

6.  Effect of ultrafiltered milk permeate and non-dairy creamer powder concentration on low phenylalanine yoghurt's physicochemical properties during storage.

Authors:  Parisa Goldar; Mohammad Hadi Givianrad; Akbar Shams
Journal:  J Food Sci Technol       Date:  2016-08-13       Impact factor: 2.701

7.  Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria.

Authors:  Thales Preissler; Ivi Juliana Bristot; Bruna May Lopes Costa; Elissa Kerli Fernandes; Elenara Rieger; Vanessa Trindade Bortoluzzi; Itiane Diehl de Franceschi; Carlos Severo Dutra-Filho; José Claudio Fonseca Moreira; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2015-11-16       Impact factor: 3.584

8.  Dietary habits and metabolic control in adolescents and young adults with phenylketonuria: self-imposed protein restriction may be harmful.

Authors:  A M Das; K Goedecke; U Meyer; N Kanzelmeyer; S Koch; S Illsinger; T Lücke; H Hartmann; K Lange; H Lanfermann; L Hoy; X-Q Ding
Journal:  JIMD Rep       Date:  2013-11-13

9.  Phenylketonuria: nutritional advances and challenges.

Authors:  Marcello Giovannini; Elvira Verduci; Elisabetta Salvatici; Sabrina Paci; Enrica Riva
Journal:  Nutr Metab (Lond)       Date:  2012-02-03       Impact factor: 4.169

Review 10.  Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.

Authors:  Jane F Ferguson; Hooman Allayee; Robert E Gerszten; Folami Ideraabdullah; Penny M Kris-Etherton; José M Ordovás; Eric B Rimm; Thomas J Wang; Brian J Bennett
Journal:  Circ Cardiovasc Genet       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.